Can we selectively target myelin repair?

Dr Jessica Fletcher

Menzies Institute for Medical Research, University of Tasmania, TAS

March 2025

specialisation: Neurobiology

focus area: A cure via repair and regeneration

funding type: Project

project type: Investigator Led Research

Summary

Dr Jessica Fletcher’s research focuses on finding ways to repair the brain in MS, where current treatments cannot fully stop disease progression. This project aims to boost the activity of myelin-producing cells, called oligodendrocytes, to encourage new myelin growth.

Dr Fletcher’s team will look for specific molecules inside oligodendrocytes that play a role in the myelin repair process. They will focus on a key molecule called Olig2, which controls whether a cell can make myelin and how much it will produce. By adjusting the activity of Olig2, the team hopes to stimulate myelin regeneration.

The goal is to develop precise treatments that target only the cells involved in myelin repair, avoiding other parts of the body.

This approach could lead to more effective and safer therapies to repair myelin in people with MS.

lead investigator

co-investigator

Associate Professor Simon Murray
Dr Kazuhide Okuda
Dr Jordan Wright

total funding

$249,599

start year

2025

duration

3 years

STATUS

Current project

Stages of the research process

Fundamental laboratory Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline

10+ years

Translational Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline

5+ years

Clinical Studies and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline

3+ years

Read More

Newsletter subscription

  • Enter your details

Can we selectively target myelin repair?